130 related articles for article (PubMed ID: 35605655)
41. Heavy ion radiation-induced DNA damage mediates apoptosis via the Rpl27a-Rpl5-MDM2-p53/E2F1 signaling pathway in mouse spermatogonia.
Li H; Zhang H; Huang G; Dou Z; Xie Y; Si J; Di C
Ecotoxicol Environ Saf; 2020 Sep; 201():110831. PubMed ID: 32535367
[TBL] [Abstract][Full Text] [Related]
42. Long noncoding RNA PiHL regulates p53 protein stability through GRWD1/RPL11/MDM2 axis in colorectal cancer.
Deng X; Li S; Kong F; Ruan H; Xu X; Zhang X; Wu Z; Zhang L; Xu Y; Yuan H; Peng H; Yang D; Guan M
Theranostics; 2020; 10(1):265-280. PubMed ID: 31903119
[TBL] [Abstract][Full Text] [Related]
43. Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism.
Dai MS; Shi D; Jin Y; Sun XX; Zhang Y; Grossman SR; Lu H
J Biol Chem; 2006 Aug; 281(34):24304-13. PubMed ID: 16803902
[TBL] [Abstract][Full Text] [Related]
44. Growth inhibitory effects of large subunit ribosomal proteins in melanoma.
Kardos GR; Dai MS; Robertson GP
Pigment Cell Melanoma Res; 2014 Sep; 27(5):801-12. PubMed ID: 24807543
[TBL] [Abstract][Full Text] [Related]
45. Effects of wild-type p53 expression on the quantity and activity of topoisomerase IIalpha and beta in various human cancer cell lines.
Hochhauser D; Valkov NI; Gump JL; Wei I; O'Hare C; Hartley J; Fan J; Bertino JR; Banerjee D; Sullivan DM
J Cell Biochem; 1999 Nov; 75(2):245-57. PubMed ID: 10502297
[TBL] [Abstract][Full Text] [Related]
46. Silencing Ribosomal Protein L22 Promotes Proliferation and Migration, and Inhibits Apoptosis of Gastric Cancer Cells by Regulating the Murine Double Minute 2-Protein 53 (MDM2-p53) Signaling Pathway.
Sun Z; Qiu Z; Wang Z; Chi H; Shan P
Med Sci Monit; 2021 May; 27():e928375. PubMed ID: 34050122
[TBL] [Abstract][Full Text] [Related]
47. Nicotine Promotes Human Papillomavirus (HPV)-Immortalized Cervical Epithelial Cells (H8) Proliferation by Activating RPS27a-Mdm2-P53 Pathway In Vitro.
Chen L; Wang H
Toxicol Sci; 2019 Feb; 167(2):408-418. PubMed ID: 30272249
[TBL] [Abstract][Full Text] [Related]
48. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.
Macias E; Jin A; Deisenroth C; Bhat K; Mao H; Lindström MS; Zhang Y
Cancer Cell; 2010 Sep; 18(3):231-43. PubMed ID: 20832751
[TBL] [Abstract][Full Text] [Related]
49. Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors.
Oloumi A; MacPhail SH; Johnston PJ; Banáth JP; Olive PL
Cancer Res; 2000 Oct; 60(20):5747-53. PubMed ID: 11059769
[TBL] [Abstract][Full Text] [Related]
50. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function.
Chen D; Zhang Z; Li M; Wang W; Li Y; Rayburn ER; Hill DL; Wang H; Zhang R
Oncogene; 2007 Aug; 26(35):5029-37. PubMed ID: 17310983
[TBL] [Abstract][Full Text] [Related]
51. The in vivo role of the RP-Mdm2-p53 pathway in signaling oncogenic stress induced by pRb inactivation and Ras overexpression.
Pan W; Issaq S; Zhang Y
PLoS One; 2011; 6(6):e21625. PubMed ID: 21747916
[TBL] [Abstract][Full Text] [Related]
52. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
53. D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms.
Liu M; Li C; Pazgier M; Li C; Mao Y; Lv Y; Gu B; Wei G; Yuan W; Zhan C; Lu WY; Lu W
Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14321-6. PubMed ID: 20660730
[TBL] [Abstract][Full Text] [Related]
54. Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation.
Liu Y; He Y; Jin A; Tikunov AP; Zhou L; Tollini LA; Leslie P; Kim TH; Li LO; Coleman RA; Gu Z; Chen YQ; Macdonald JM; Graves LM; Zhang Y
Proc Natl Acad Sci U S A; 2014 Jun; 111(23):E2414-22. PubMed ID: 24872453
[TBL] [Abstract][Full Text] [Related]
55. Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop.
Zhang X; Wang W; Wang H; Wang MH; Xu W; Zhang R
Oncogene; 2013 May; 32(22):2782-91. PubMed ID: 22777350
[TBL] [Abstract][Full Text] [Related]
56. Nuclear factor-Y binding to the topoisomerase IIalpha promoter is inhibited by both the p53 tumor suppressor and anticancer drugs.
Joshi AA; Wu Z; Reed RF; Suttle DP
Mol Pharmacol; 2003 Feb; 63(2):359-67. PubMed ID: 12527807
[TBL] [Abstract][Full Text] [Related]
57. Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway.
Horn HF; Vousden KH
Oncogene; 2008 Oct; 27(44):5774-84. PubMed ID: 18560357
[TBL] [Abstract][Full Text] [Related]
58. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop.
Arriola EL; Lopez AR; Chresta CM
Oncogene; 1999 Jan; 18(4):1081-91. PubMed ID: 10023685
[TBL] [Abstract][Full Text] [Related]
59. 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint.
Donati G; Peddigari S; Mercer CA; Thomas G
Cell Rep; 2013 Jul; 4(1):87-98. PubMed ID: 23831031
[TBL] [Abstract][Full Text] [Related]
60. Ling Zhi-8 mediates p53-dependent growth arrest of lung cancer cells proliferation via the ribosomal protein S7-MDM2-p53 pathway.
Wu CT; Lin TY; Hsu HY; Sheu F; Ho CM; Chen EI
Carcinogenesis; 2011 Dec; 32(12):1890-6. PubMed ID: 21983128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]